244 related articles for article (PubMed ID: 28924113)
1. The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD).
Ohgiya M; Matsui H; Tamura A; Kato T; Akagawa S; Ohta K
Intern Med; 2017 Oct; 56(20):2711-2717. PubMed ID: 28924113
[TBL] [Abstract][Full Text] [Related]
2. Interstitial Lung Abnormalities and the Clinical Course in Patients With COPD.
Lee TS; Jin KN; Lee HW; Yoon SY; Park TY; Heo EY; Kim DK; Chung HS; Lee JK
Chest; 2021 Jan; 159(1):128-137. PubMed ID: 32805240
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
4. The impact of heart failure on the classification of COPD severity.
Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of interstitial lung abnormalities on CT in patients with COPD using artificial intelligence-based segmentation: a prospective observational study.
Shiraishi Y; Tanabe N; Sakamoto R; Maetani T; Kaji S; Shima H; Terada S; Terada K; Ikezoe K; Tanizawa K; Oguma T; Handa T; Sato S; Muro S; Hirai T
BMC Pulm Med; 2024 Apr; 24(1):200. PubMed ID: 38654252
[TBL] [Abstract][Full Text] [Related]
6. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
[TBL] [Abstract][Full Text] [Related]
7. Are interstitial lung abnormalities associated with COPD? A nested case-control study.
Bozzetti F; Paladini I; Rabaiotti E; Franceschini A; Alfieri V; Chetta A; Crisafulli E; Silva M; Pastorino U; Sverzellati N
Int J Chron Obstruct Pulmon Dis; 2016; 11():1087-96. PubMed ID: 27307724
[TBL] [Abstract][Full Text] [Related]
8. Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.
Marçôa R; Rodrigues DM; Dias M; Ladeira I; Vaz AP; Lima R; Guimarães M
COPD; 2018 Feb; 15(1):21-26. PubMed ID: 29161163
[TBL] [Abstract][Full Text] [Related]
9. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
[TBL] [Abstract][Full Text] [Related]
10. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
11. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
[TBL] [Abstract][Full Text] [Related]
12. Impact of Interstitial Lung Abnormalities on Disease Expression and Outcomes in COPD or Emphysema: A Systematic Review.
Liu Y; Tang J; Sun Y
Int J Chron Obstruct Pulmon Dis; 2023; 18():189-206. PubMed ID: 36890863
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection.
Sangani RG; Deepak V; Ghio AJ; Forte MJ; Zulfikar R; Patel Z; King A; Alshaikhnassir E; Abbas G; Vos J
BMC Pulm Med; 2022 Apr; 22(1):172. PubMed ID: 35488260
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.
Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
PLoS One; 2015; 10(1):e0115787. PubMed ID: 25625286
[TBL] [Abstract][Full Text] [Related]
15. [Sixty-four slice spiral CT low-dose chest two-phase scanning for lung density measurement in assessing the pulmonary function in patients with chronic obstructive pulmonary disease].
Zhang L; Wang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 37(11):1156-62. PubMed ID: 23202631
[TBL] [Abstract][Full Text] [Related]
16. Significance of Low-Attenuation Cluster Analysis on Quantitative CT in the Evaluation of Chronic Obstructive Pulmonary Disease.
Nambu A; Zach J; Kim SS; Jin G; Schroeder J; Kim YI; Bowler R; Lynch DA
Korean J Radiol; 2018; 19(1):139-146. PubMed ID: 29354010
[TBL] [Abstract][Full Text] [Related]
17. COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors.
Beghé B; Cerri S; Fabbri LM; Marchioni A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502194
[TBL] [Abstract][Full Text] [Related]
18. COPD in chronic heart failure: less common than previously thought?
Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
Chun EM; Kim SW; Lim SY
Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
[TBL] [Abstract][Full Text] [Related]
20. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
